Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis

NCT01943617 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

606

Enrollment

OTHER

Sponsor class

Conditions

Liver Cirrhosis

Interventions

DRUG: Entecavir
DRUG: Thymosin-α

Sponsor

Beijing Friendship Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]